3.9 Article

Comparison of Capillary Electrophoresis with Cellulose Acetate Electrophoresis for the Screening of Hemoglobinopathies

Journal

KOREAN JOURNAL OF LABORATORY MEDICINE
Volume 31, Issue 4, Pages 238-243

Publisher

KOREAN SOC LABORATORY MEDICINE
DOI: 10.3343/kjlm.2011.31.4.238

Keywords

Capillary electrophoresis; Thalassemia; Hemoglobinopathies

Funding

  1. Korea Science and Engineering Foundation (KOSEF)
  2. Korean government (MEST) [R13-2002-044-05002-0]

Ask authors/readers for more resources

Background: beta-thalassemia is primarily found in individuals of Mediterranean and Southeast Asian ancestry. With rapid growth in the Southeast Asian segments of the Korean population, the geographic distribution of hemoglobinopathies is expected to become significantly different from what it is today. In this study, Hb fractions were measured in patients with hypochromic microcytosis to detect thalassemia and Hb variants. To evaluate the feasibility of replacing cellulose acetate electrophoresis (CA) with capillary electrophoresis (CE) in a clinical laboratory, both techniques were performed and the outcomes were compared. Methods: To evaluate hemoglobinopathies, complete blood cell counts (CBC), CA, and CE were carried out on samples from healthy and microcytic hypochromic groups. The microcytic hypochromic group consisted of 103 patients whose mean corpuscular volume (MCV) was less than 75 fL and mean corpuscular hemoglobin (MCH) was less than 24 pg. Quantitative analysis of Hb fractions was performed on 143 whole blood samples. Results: There was a good correlation for measurements of HbA (r = 0.9370, P < 0.0001), HbA(2) (r = 0.8973 P < 0.0001), and HbF (r = 0.8010, P = 0.0304) between the two methods. In the microcytic hypochromic group, there were 29 cases (28.2%) with decreased HbA(2), 2 cases (1.9%) with increased HbA(2), 3 cases (2.9%) with increased HbF, and 2 cases (1.9%) with increased HbA(2) and HbF. Conclusions: CE is comparable to CA for reliable measurement of Hb fractions. It is suitable for screening of hemoglobinopathies in many clinical laboratories.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available